Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis

N Engl J Med. 2011 Jan 6;364(1):83; author reply 84. doi: 10.1056/NEJMc1012187.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aminopyridines
  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Intracellular Signaling Peptides and Proteins / antagonists & inhibitors*
  • Methotrexate / administration & dosage*
  • Morpholines
  • Oxazines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyridines / therapeutic use*
  • Pyrimidines
  • Syk Kinase

Substances

  • Aminopyridines
  • Antirheumatic Agents
  • Intracellular Signaling Peptides and Proteins
  • Morpholines
  • Oxazines
  • Protein Kinase Inhibitors
  • Pyridines
  • Pyrimidines
  • Protein-Tyrosine Kinases
  • SYK protein, human
  • Syk Kinase
  • fostamatinib
  • Methotrexate